Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,323 | 29 | 69.1% |
| Food and Beverage | $5,062 | 343 | 30.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $8,488 | 19 | $0 (2022) |
| ABBVIE INC. | $4,541 | 138 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $468.49 | 33 | $0 (2022) |
| Janssen Biotech, Inc. | $335.00 | 35 | $0 (2023) |
| Lilly USA, LLC | $295.78 | 20 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $283.67 | 14 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $243.35 | 17 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $237.20 | 12 | $0 (2023) |
| PFIZER INC. | $203.67 | 15 | $0 (2023) |
| Galderma Laboratories, L.P. | $182.21 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,357 | 33 | ABBVIE INC. ($1,195) |
| 2023 | $2,807 | 55 | ABBVIE INC. ($2,241) |
| 2022 | $8,014 | 49 | Allergan, Inc. ($7,305) |
| 2021 | $1,771 | 54 | Allergan, Inc. ($1,134) |
| 2020 | $292.19 | 19 | AbbVie Inc. ($141.91) |
| 2019 | $639.17 | 52 | AbbVie, Inc. ($167.57) |
| 2018 | $683.79 | 47 | AbbVie, Inc. ($128.50) |
| 2017 | $819.92 | 63 | Galderma Laboratories, L.P. ($144.00) |
All Payment Transactions
372 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $67.94 | General |
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.80 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $129.33 | General |
| 11/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $24.74 | General |
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: DERMATOLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $26.75 | General |
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $73.15 | General |
| 09/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $42.50 | General |
| 08/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $146.32 | General |
| 06/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $82.60 | General |
| 05/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Immunology | ||||||
| 05/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.10 | General |
| 05/01/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $11.47 | General |
| 04/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $114.68 | General |
| 04/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: Immunology | ||||||
| 03/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,940 | 3,181 | $280,084 | $104,086 |
| 2022 | 14 | 1,727 | 2,705 | $246,205 | $93,004 |
| 2021 | 15 | 1,436 | 2,207 | $199,793 | $74,903 |
| 2020 | 16 | 1,765 | 2,917 | $261,041 | $91,080 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 454 | 580 | $63,800 | $32,022 | 50.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 219 | 251 | $46,686 | $14,702 | 31.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 179 | 208 | $33,904 | $14,598 | 43.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 335 | 416 | $49,920 | $13,635 | 27.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 318 | 371 | $24,486 | $12,164 | 49.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 237 | 1,078 | $26,950 | $4,639 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 44 | $7,172 | $3,266 | 45.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 20 | 24 | $8,664 | $2,625 | 30.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 18 | $4,878 | $2,301 | 47.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 42 | 51 | $5,202 | $1,839 | 35.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $5,216 | $1,471 | 28.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 19 | 19 | $2,147 | $623.96 | 29.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 22 | $858.00 | $154.66 | 18.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 67 | $201.00 | $45.79 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 423 | 517 | $56,870 | $28,727 | 50.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 182 | 196 | $31,948 | $13,654 | 42.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 194 | 217 | $40,362 | $12,807 | 31.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 294 | 351 | $42,120 | $11,792 | 28.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 96 | 96 | $15,648 | $6,469 | 41.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 169 | 188 | $12,452 | $6,085 | 48.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 208 | 903 | $22,575 | $4,156 | 18.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 18 | 23 | $6,233 | $2,524 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 31 | $5,053 | $2,386 | 47.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 35 | 45 | $4,590 | $1,591 | 34.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 15 | 17 | $3,791 | $1,533 | 40.4% |
About Dr. Jennifer Hobbs, M.D
Dr. Jennifer Hobbs, M.D is a Dermatology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134227911.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Hobbs, M.D has received a total of $16,385 in payments from pharmaceutical and medical device companies, with $1,357 received in 2024. These payments were reported across 372 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,323).
As a Medicare-enrolled provider, Hobbs has provided services to 6,868 Medicare beneficiaries, totaling 11,010 services with total Medicare billing of $363,072. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Procedural Dermatology
- Location Fort Wayne, IN
- Active Since 09/20/2006
- Last Updated 03/07/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1134227911
Products in Payments
- COSENTYX (Biological) $468.49
- SKYRIZI (Biological) $453.12
- RINVOQ (Biological) $369.92
- Humira (Biological) $369.32
- TALTZ (Drug) $295.78
- Sotyktu (Drug) $228.51
- DUPIXENT (Biological) $177.66
- STELARA (Biological) $165.85
- EUCRISA (Drug) $161.23
- HUMIRA (Biological) $130.90
- TREMFYA (Drug) $130.02
- ILUMYA (Biological) $118.66
- DUPIXENT DUPILUMAB INJECTION (Biological) $117.23
- Cimzia (Drug) $96.19
- DUPIXENT (Drug) $91.25
- OPZELURA (Drug) $87.79
- REMICADE (Biological) $69.78
- Bimzelx (Biological) $68.23
- ILUMYA (tildrakizumab-asmn) injection (Biological) $66.39
- GUSELKUMAB (Biological) $65.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fort Wayne
Dr. Edward Sarkisian, M.d, M.D
Dermatology — Payments: $23,286
Ms. Jacquelyn Beemer, Pa-C, PA-C
Dermatology — Payments: $18,160
Dr. Rohit Kakar, M.d, M.D
Dermatology — Payments: $12,651
Dr. Dara Spearman, Md, MD
Dermatology — Payments: $9,722
Patrick Veerkamp, M.d, M.D
Dermatology — Payments: $9,379
Dr. Diane Hentz, M.d, M.D
Dermatology — Payments: $8,441